Clinical TrialsSearch results
Number of results: 778
Other
- Efficacy of entecavir for chronic hepatitis B patients after curative treatment of hepatocellular carcinoma :randomized controlled trial
- Chronic hepatitis B
- University of Tokyo Department of Gastroenterology, Faculty of Medicine
- 2008-01-30
Recruiting
- A multicenter single arm phase I study of concurrent radiation and gemcitabine plus cisplatin with durvalumab(MEDI4736) for advanced biliary tract cancer
- Biliary tract neoplasms
- Ueno Makoto
- 2023-10-06
Recruiting
- JCOG1904: A randomized controlled phase III trial of comparing local field with additional prophylactic irradiation in chemoradiotherapy for clinical-T1bN0M0 esophageal cancer
- esophageal cancer
- TSUSHIMA Takahiro
- 2020-07-14
Other
- Clinical Investigation of Efficacy and Safety in Second-line Bevacizumab treatment combined with FOLFIRI or FOLFOX for metastatic colorectal cancer
- colorectal cancer
- Tsukuba Cancer Clinical Trial Group
- 2008-12-03
Other
- Multicenter phase II study of S-1 plus Weekly Cisplatin in first-line treatment of unresectable or reccurent gastric cancer
- gastric cancer
- Tsukuba Cancer Clinical Trial Group
- 2009-04-07
Recruiting
- The simplicity of the single-puncture Clavipectoral fascia plane block
- clavicle fracture
- Tsuge Masatsugu
- 2024-07-31
Recruiting
- JCOG1807C: Efficacy and safety of durvalumab before and after operation after chemoradiotherapy against superior sulcus non-small cell lung cancer
- superior sulcus non-small cell lung cancer
- TSUBOI Masahiro
- 2020-03-01
Other
- JCOG1205/1206: A Phase III Study Comparing Irinotecan and Cisplatin with Etoposide and Cisplatin for Adjuvant Chemotherapy of Completely Resected Pulmonary High-grade Neuroendocrine Carcinoma
- Pulmonary High-grade Neuroendocrine Carcinoma
- TSUBOI Masahiro
- 2019-03-08
Other
- Multi-institute randomized study of natural type interferon alpha for patients with renal cell carcinoma after radical nephrectomy
- Renal cell carcinoma
- TRAIn-Alpha study group
- 2005-09-30
Other
- Phase 3 Study to Evaluate the Effect of 10 mg Obicetrapib in Participants With Underlying HeFH and/or Atherosclerotic Cardiovascular Disease (ASCVD)
- Dyslipidemia
- Toshihiro Hokonohara
- 2022-07-30